Late onset of medullary thyroid carcinoma with bilateral adrenal pheochromocytomas in the case of patient with MEN 2;Późne ujawnienie siȩ raka rdzeniastego tarczycy u chorej z obustronnymi guzami chromochłonnymi nadnerczy w przebiegu zespołu wielonarza̧dowej gruczolakowatości wewna̧trzwydzielniczej

Polski Merkuriusz Lekarski

Volumn 17, Issue 102, 2004, Pages 633-637

  Zakrzewska, Agnieszka ^a,b   Makowska, Anna M ^a   Bar Andziak, Ewa ^a  

^a Pneumonologii i Alergol A M w W   (Poland)

^b Samodzielny Publiczny Centralny S   (Poland)

Author keywords

Medullary thyroid cancer; Multiple endocrine neoplasia (MEN 2A); Pheochromocytoma

Indexed keywords

CALCITONIN; CATECHOLAMINE; PROTEIN RET;

ADRENAL MEDULLA TUMOR; ADRENALECTOMY; ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CASE REPORT; CATECHOLAMINE URINE LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CYTODIAGNOSIS; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FLUSHING; FOLLOW UP; GENE MUTATION; HEART PALPITATION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LEUKOCYTE; ONCOGENE RET; PHEOCHROMOCYTOMA; SEQUENCE ANALYSIS; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; CARCINOMA, MEDULLARY; CATECHOLAMINES; FEMALE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; POTASSIUM CHANNELS; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 11844264810     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Altanerova V.: Cancers connected with mutations in RET protooncogene. Neoplasma, 2001, 48, 325-331.
2. Braverman L.E., Utiger R.D.: The thyroid. J.B. Lippincott Com. 1991, 1174.
3. Copp D.H., Cameron E.C., Cheney B.A.: Evidence for calcitonin: a new hormone from the parathyroid that lowers blood calcium. Endocrinology, 1962, 70, 638.
4. Cote G.J., Gagel R.F.: Lessons Learned from the management of a rare genetic cancer. NEJM, 2003, 349, 1566-1568.
5. Donovan D.T., Levy M.L., Furst E.J.: Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia neoplasia type 2A: A new variant. Henry Ford Hosp. Med. J., 1989, 37, 147.
6. Eng C., Mulligan L.M., Healey C.S. i wsp.: Heterogeneous mutation of the RET proto-oncogen in subpopulation of medullary thyroid carcinoma. Cancer Res., 1996, 56, 2167-2170.
7. Foster G.V., Mac Intyre I., Pearse A.G.E.: Calcitonin production and the mitochondrion - rich cells of the dog thyroid. Nature, 1964, 203, 1029.
8. Frank-Raue K., Heimbach C., Rondot S. i wsp.: Hereditary medullary thyroid carcinoma - genotype-phenotype chracterisation. Dtsch. Med. Wochenschr., 2003, 128, 1998-2002.
9. Franz M.G.: Medullary thyroid cancer. Cancer Control, 1997, 4, 25-29.
10. Greenspan F.S., Gardner D.G.: Basic and Clinical Endocrinology. Lange. Medical Books Chapter, 8, 288-289.
11. Hazard J.B., Hawk W.A., Crile G. Jr.: Medullary carcinoma of the thyroid: a clinicopathologic entity. J. Clin. Endocrinol. Metab., 1959, 19, 152.
12. Ishizu K., Shiraishi K., Kawamura H. i wsp.: A case of multiple endocrine neoplasia type 2A (MEN 2A) with a mutation in the RET gene. Hinyokika Kiyo, 1999, 45, 407-410.
13. Machens A., Niccoli-Sire P., Hoegel J. i wsp.: Early malignant progression of hereditary medullary thyroid cancer. NEJM, 2003, 349, 1517-1525.
14. Modigliani E., Franc B., Niccoli-Sire P.: Diagnosis and treatment of medullary thyroid cancer. Bailliers. Best Pract. Res. Clin. Endocrinol. Metab., 2000, 14, 631-649.
15. Phay J.E., Moley J.F., Lairmore T.C.: Multiple endocrine neoplasias. Semin. Surg. Oncol., 2000, 18, 324-332.
16. Pomorski L., Bartkowiak J., Pisarek H. i wsp.: Medullary thyroid carcinoma (MTC) - clinical and molecular aspects on the basis of own experience. Neoplasma, 2000, 47, 323-326.
17. Sipple J.H.: The association of phaeochromocytoma with carcinoma of the thyroid gland. Am. J. Med., 1961, 31, 163-166.
18. Włoch J., Wygoda Z., Wiench M. i wsp.: Consequences of clinical genetic analysis of RET protooncogene. Wiad. Lek., 2001, 54, Suppl. 1, 406-414.
19. Wygoda Z., Włoch J., Gubała E. i wsp.: B Results of treating medullary thyroid carcinoma: the differences between sporadic and inherited forms. Wiad. Lek., 2001, suppl. 1, 422-431.